No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PODD240517C170000
- 15.50
- +1.75+12.73%
15min DelayClose May 17 15:58 ET
15.50High14.30Low
14.30Open13.75Pre Close10 Volume0 Open Interest170.00Strike Price15.18KTurnover0.00%IV-0.30%PremiumMay 17, 2024Expiry Date17.27Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma11.21Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
These large-cap stocks were the best performers in the last week. Are they in your portfolio?MicroStrategy Incorporated (NASDAQ:MSTR) shares increased 30.10% following a rise in the price of Bitcoin.M
Insulet's Strong Market Position and Financial Health Merit a Buy Rating Despite Legal Challenges
Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
On Tuesday, Blue Orca Capital released a report on Insulet Corporation (NASDAQ:PODD), saying it is short on the insulin delivery patch pump manufacturer.The report added that Blue Orca is long on its
Express News | Zer0es.tv Previews Video On X Saying "Soren Aandahl of @blueorcainvest Is Out Today With Their Latest Idea: Short Insulet Corporation ( $PODD) and Long Its Upstart Korean Competitor EOFlow Because, Undisclosed to Investors, Last Week the Federal Court...
Express News | Blue Orca Says We Are Short Insulet
Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Insulet (PODD) and Crispr Therapeutics AG (CRSP)
Comments
Here are the WORST 10 S&P 500 stock performers in Q1 (YTD):
Tesla $Tesla(TSLA.US$ : -28.50% 🔻
Boeing $Boeing(BA.US$ : -28.07% 🔻
MarketAxess $MarketAxess(MKTX.US$ : -26.75% 🔻
Warner Bros $Warner Bros Discovery(WBD.US$ : -26.36% 🔻
Charter Communications $Charter Communications(CHTR.US$ : -25.93% 🔻
Lululemon $Lululemon Athletica(LULU.US$ : -24.48% 🔻
VF Corp $VF Corp(VFC.US$ : -24.15% 🔻
Humana $Humana(HUM.US$ : -23.90% 🔻
Insulet $Insulet(PODD.US$ : -23.72% 🔻
Paramount $Paramount Global-B(PARA.US$ : -23.12%...
Tesla $Tesla(TSLA.US$ : -28.50% 🔻
Boeing $Boeing(BA.US$ : -28.07% 🔻
MarketAxess $MarketAxess(MKTX.US$ : -26.75% 🔻
Warner Bros $Warner Bros Discovery(WBD.US$ : -26.36% 🔻
Charter Communications $Charter Communications(CHTR.US$ : -25.93% 🔻
Lululemon $Lululemon Athletica(LULU.US$ : -24.48% 🔻
VF Corp $VF Corp(VFC.US$ : -24.15% 🔻
Humana $Humana(HUM.US$ : -23.90% 🔻
Insulet $Insulet(PODD.US$ : -23.72% 🔻
Paramount $Paramount Global-B(PARA.US$ : -23.12%...
5
$Insulet(PODD.US$ Why it drops?
Despite low ROCE, Insulet's consistent reinvestment at increasing rates and growing capital employed are positive signs. The stock's 112% return over five years shows investor optimism.
Positive EPS growth and share price decrease may signal an opportunity for investors. Long term shareholders gained 19% annually over five years. The recent sell-off could be a chance if fundamentals indicate long term growth.
Read more